At the 2025 ASCRS meeting, Dr. Sarkisian presented 3-year data on the iDose TR from the FDA clinical trial.
Steven R. Sarkisian Jr., MD, ABO
Advertisement
Articles by Steven R. Sarkisian Jr., MD, ABO
Advertisement
Latest Updated Articles
Nitric Oxide and Its Important Role in the Trabecular Meshwork of Glaucoma PatientsPublished: December 21st 2018 | Updated:
Advertisement
Advertisement
.png "Optometry Times"){kind=logo}
